|
CSNK2A2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.1495999998692E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.99499999975883E-07 |
| Normal-vs-Stage2 |
5.625300E-04 |
| Normal-vs-Stage3 |
1.950080E-04 |
| Normal-vs-Stage4 |
1.24820000002579E-06 |
| Stage1-vs-Stage2 |
9.104600E-01 |
| Stage1-vs-Stage3 |
4.672000E-01 |
| Stage1-vs-Stage4 |
4.078500E-02 |
| Stage2-vs-Stage3 |
5.349800E-01 |
| Stage2-vs-Stage4 |
1.587610E-01 |
| Stage3-vs-Stage4 |
2.629800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.65379999980975E-07 |
| Normal-vs-AfricanAmerican |
6.881200E-03 |
| Normal-vs-Asian |
2.10769999999805E-05 |
| Caucasian-vs-AfricanAmerican |
6.480400E-01 |
| Caucasian-vs-Asian |
1.963000E-01 |
| AfricanAmerican-vs-Asian |
6.836400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.25709999965196E-07 |
| Normal-vs-Female |
4.78969999995194E-07 |
| Male-vs-Female |
2.833600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.76830000045925E-07 |
| Normal-vs-Age(41-60Yrs) |
5.79349999973999E-07 |
| Normal-vs-Age(61-80Yrs) |
3.87570000004445E-06 |
| Normal-vs-Age(81-100Yrs) |
5.433800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.556000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.190600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.379980E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.803000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.472790E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.439440E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.722600E-01 |
| Classical-VS-Follicular |
1.560950E-01 |
| Classical-VS-Other |
2.166200E-01 |
| Classical-VS-Normal |
2.97069999710686E-08 |
| Tall-VS-Follicular |
4.201200E-01 |
| Tall-VS-Other |
2.523200E-01 |
| Tall-VS-Normal |
2.758400E-04 |
| Follicular-VS-Other |
1.087770E-01 |
| Follicular-VS-Normal |
5.408300E-04 |
| Other-VS-Normal |
4.323900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.17540000030981E-07 |
| Normal-vs-N1 |
2.484500E-03 |
| N0-vs-N1 |
6.217200E-01 |
|
|
